EUVIMEDEUVIMED entdecken
Crossref

MMP9‐Responsive Graphene Oxide Quantum Dot‐Based Nano‐in‐Micro Drug Delivery System for Combinatorial Therapy of Choroidal Neovascularization

Keke Huang, Xin Liu, Ziru Lv, Di Zhang, Yuling Zhou, Zhiqing Lin, Juan Guo iD

Small · 2023

DOI: 10.1002/smll.202207335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2023. Verfasst von Keke Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Advanced Materials for Nano-Bio Applications, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, …. Hauptthemen laut MEDLINE: Quantum Dots, Choroidal Neovascularization. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age‐related macular degeneration (AMD), especially wet AMD with choroidal neovascularization (CNV), commonly causes blindness in older patients and disruption of the choroid followed by second‐wave injuries, including chronic inflammation, oxidative stress, and excessive matrix metalloproteinase 9 (MMP9) expression. Increased macrophage infiltrate in parallel with microglial activation and MMP9 overexpression on CNV lesions is shown to contribute to the inflammatory process and then enhance pathological ocular angiogenesis. Graphene oxide quantum dots (GOQDs), as natural antioxidants, exert anti‐inflammatory effects and minocycline is a specific macrophage/microglial inhibitor that can suppress both macrophage/microglial activation and MMP9 activity. Herein, an MMP9‐responsive GOQD‐based minocycline‐loaded nano‐in‐micro drug delivery system (C18PGM) is developed by chemically bonding GOQDs to an octadecyl‐modified peptide sequence (C18‐GVFHQTVS, C18P) that can be specifically cleaved by MMP9. Using a laser‐induced CNV mouse model, the prepared C18PGM shows significant MMP9 inhibitory activity and anti‐inflammatory action followed by antiangiogenic effects. Moreover, C18PGM combined with antivascular endothelial growth factor antibody bevacizumab markedly increases the antiangiogenesis effect by interfering with the “inflammation‐MMP9‐angiogenesis” cascade. The prepared C18PGM shows a good safety profile and no obvious ophthalmic or systemic side effects. The results taken together suggest that C18PGM is an effective and novel strategy for combinatorial therapy of CNV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quantum DotsChoroidal NeovascularizationHumansMiceAnimalsAgedMatrix Metalloproteinase 9MinocyclineVascular Endothelial Growth Factor ADrug Delivery SystemsAngiogenesis InhibitorsInflammationDisease Models, AnimalMice, Inbred C57BLGraphite

Stichwörter der Autor:innen

anti-inflammationantiangiogenesischoroidal neovascularizationcombinatorial therapymatrix metalloproteinase 9vascular endothelial growth factor (VEGF)

Substanzen

Matrix Metalloproteinase 9MinocyclineVascular Endothelial Growth Factor AAngiogenesis Inhibitorsgraphene oxideGraphiteMMP9 protein, human

Autor:innen und Institutionen

  • Institute of Advanced Materials for Nano-Bio Applications, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, P. R. China.
  • Department of ophthalmology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, Hubei, 435000, P. R. China.
  • Department of Ophthalmology, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, 610031, P. R. China.

ORCID-Profile: Juan Guo

Förderung

  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Huang, K., Liu, X., Lv, Z., Zhang, D., Zhou, Y., Lin, Z., & Guo, J. (2023). MMP9‐Responsive Graphene Oxide Quantum Dot‐Based Nano‐in‐Micro Drug Delivery System for Combinatorial Therapy of Choroidal Neovascularization. Small. https://doi.org/10.1002/smll.202207335

Vancouver

Huang K, Liu X, Lv Z, Zhang D, Zhou Y, Lin Z, et al. MMP9‐Responsive Graphene Oxide Quantum Dot‐Based Nano‐in‐Micro Drug Delivery System for Combinatorial Therapy of Choroidal Neovascularization. Small. 2023. doi:10.1002/smll.202207335

BibTeX
@article{Huang2023,
  author = {Huang, Keke and Liu, Xin and Lv, Ziru and Zhang, Di and Zhou, Yuling and Lin, Zhiqing and Guo, Juan},
  title = {MMP9‐Responsive Graphene Oxide Quantum Dot‐Based Nano‐in‐Micro Drug Delivery System for Combinatorial Therapy of Choroidal Neovascularization},
  journal = {Small},
  year = {2023},
  doi = {10.1002/smll.202207335}
}
Kostenlos starten →